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Spondylocostal dysostosis (SCD) is a term given to a heterogeneous group of disorders characterized by abnormal
vertebral segmentation (AVS). We have previously identified mutations in the Delta-like 3 (DLL3) gene as a major
cause of autosomal recessive spondylocostal dysostosis. DLL3 encodes a ligand for the Notch receptor and, when
mutated, defective somitogenesis occurs resulting in a consistent and distinctive pattern of AVS affecting the entire
spine. From our study cohort of cases of AVS, we have identified individuals and families with abnormal segmentation
of the entire spine but no mutations in DLL3, and, in some of these, linkage to the DLL3 locus at 19q13.1 has
been excluded. Within this group, the radiological phenotype differs mildly from that of DLL3 mutation–positive
SCD and is variable, suggesting further heterogeneity. Using a genomewide scanning strategy in one consanguineous
family with two affected children, we demonstrated linkage to 15q21.3-15q26.1 and furthermore identified a 4-
bp duplication mutation in the human MESP2 gene that codes for a basic helix-loop-helix transcription factor. No
MESP2 mutations were found in a further 7 patients with related radiological phenotypes in whom abnormal
segmentation affected all vertebrae, nor in a further 12 patients with diverse phenotypes.
The spondylocostal dysostoses (SCD [MIM 277300])
are a heterogeneous group of disorders with severe axial
skeletal malformation characterized radiologically by
multiple vertebral segmentation defects (MVSD). In ad-
dition, the ribs are frequently malaligned, with points
of fusion and sometimes a reduction in number. The
diverse SCD phenotypes have been reviewed elsewhere
(Turnpenny and Kusumi 2003). Sporadic cases occur
more commonly than familial ones and are more likely
to be associated with multiple congenital abnormalities,
whereas monogenic forms more commonly demonstrate
autosomal recessive (AR) rather than autosomal domi-
nant inheritance. We previously demonstrated linkage in
some families with AR SCD to chromosome 19q13.1
(Turnpenny et al. 1999), a region syntenic to the Dll3
homologue on mouse chromosome 7. Mutations in mu-
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rine Dll3 result in the “Pudgy” phenotype (Kusumi et
al. 1998), and we subsequently identified mutations in
the human Delta-like 3 (DLL3 [MIM 602768]) gene
(Bulman et al. 2000). We and others have characterized
17 familial mutations in DLL3, including nonsense,mis-
sense, frameshift, and splice-site mutations, all of which
are likely to lead to functional null alleles either by pre-
mature truncation of the protein or by the substitution
of essential amino acid residues (Bulman et al. 2000;
Sparrow et al. 2002; Bonafe´ et al. 2003; Turnpenny et
al. 2003).
Here we have studied a consanguineous family of Leb-
anese Arab origin with two offspring affected with SCD
(fig. 1). Affected individuals presented with truncal
shortening and short necks but no other abnormalities.
On radiological examination, thoracic vertebrae bear a
resemblance to those seen in SCD due to mutatedDLL3,
but the lumbar vertebrae appear more angular and ir-
regular. The vertebral morphology, with regional differ-
ences throughout the spine, is highlighted by MR im-
aging (fig. 2). By use of genomic DNA extracted from
blood samples from all five available family members,
flanking microsatellite markers excluded linkage to the
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Figure 1 Pedigree of the family affected with SCD, MESP2 type, demonstrating disease-linked haplotype. Affected members II.2 and II.3
are indicated by fully blackened symbols.
19q13.1/DLL3 locus. Subsequent genomewide homo-
zygosity mapping, performed using the Perkin Elmer
Biosystems Linkage Mapping Set (version 1) with af-
fected genomic DNA from individual II.2, revealed 84
homozygous markers scattered throughout the genome,
of which 6 were concentrated in a block on 15q
(D15S153 to D15S120) and 5 were concentrated in a
block on 20q (D20S117 to D20S186). Subsequent map-
ping, performed using the second affected individual
II.3 and the unaffected sibling II.1, excluded linkage to
the 20q region but demonstrated linkage to the 15q
markers—namely, D15S153, D15S131, D15S205, and
D15S127. Subsequent fine mapping, performed using
additional markers, demonstrated a 36.6-Mb region
(according to The Human Genome Working Draft)
on 15q21.3-15q26.1 between markers D15S117 and
D15S1004 with a maximum two-point LOD score of
1.588 at for markers D15S131, D15S205,vp 0
D15S1046, and D15S127 (table 1). The region between
markers D15S117 and D15S1004 contains 150 genes
and is syntenic to mouse chromosome 7, which contains
the Mesp2 gene (MESP2 [MIM 605195]). The Mesp2-
knockout mouse manifests altered rostro-caudal polar-
ity, resulting in axial skeletal defects (Saga et al. 1997).
The mouse gene was located using the Blat algorithm at
The Human Genome Working Draft with MesP2 cDNA
accession no. NM_008589, and the human gene was
located, again using the Blat and Comparative Genome
algorithms of The Human Genome Working Draft.
Analysis of the predicted human gene, MESP2, reveals
a two-exon gene spanning ∼2 kb of 15q26.1. Direct
sequencing of MESP2 gene in the two affected individ-
uals, by use of the primers M1 1F (5′-GAC ACC TCT
CTG CAA CC TG-3′), M1 1R (5′-CCT GGA GTA GAT
AAG CTG GG-3′), M1 2F (5′-CCA GCC ATA CCA
TGG CAA C-3′), and M2 2R (5′-CCA AGC TAC AGG
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Figure 2 Anteroposterior MRI of the spine of individual II.2.
The morphology of the thoracic spine and the upper cervical spine is
severely disrupted, with multiple hemivertebrae, whereas the remain-
ing regions show less severe disruption.
Table 1
Two-Point LOD Scores between ARSCD Type 2 and Chromosome
15q Markers
MARKER
Z AT v p
.00 .05 .10 .20 .30 .40 .50
D15S117  .282 .085 .020 .273 .015 .000
D15S155 1.125 .991 .857 .594 .353 .151 .000
D15S153 .034 .026 .019 .095 .004 .001 .000
D15S983 1.125 .991 .857 .594 .353 .151 .000
D15S131 1.588 1.420 1.248 .895 .550 .239 .000
D15S1026 1.125 .991 .857 .594 .353 .151 .000
D15S114 1.125 .991 .857 .594 .353 .151 .000
D15S205 1.588 1.420 1.248 .895 .550 .239 .000
D15S1046 1.588 1.420 1.248 .895 .550 .239 .000
D15S127 1.588 1.420 1.248 .895 .550 .239 .000
D15S1004  1.137 .653 .266 .103 .025 .000
D15S130  .282 .085 .020 .273 .015 .000
D15S120  1.929 1.148 .488 .200 .059 .000
NOTE.—All values are calculated under the assumption of 100%
penetrance, a disease allele frequency of 0.0001, and a disease hap-
lotype frequency of 0.1.
ACT GAT TC-3′), demonstrated a homozygous 4-bp
(ACCG) duplication mutation in exon 1, termed “500–
503dup” (fig. 3). The parents, I.1 and I.2, were shown
to be heterozygous, and the unaffected sibling, II.1, was
shown to be homozygous normal. Thus, the duplication
segregates with the disease in this family. In addition,
fluorescent PCR excluded this mutation from 68 eth-
nically matched control chromosomes. In analysis of the
genomic structure of theMESP2 gene, we note that there
is a discrepancy between the Sanger Centre and NCBI
human genomic assembly databases. In the latter, there
is an additional short intron located after base 502 of
the MESP2 coding region. This does not appear in the
Ensembl gene prediction, and, due to a lack of consensus
splice sites within this proposed intronic sequence, we
do not believe this intron exists. Clarification of this issue
would necessitate transcript isolation and sequence anal-
ysis. This would be a difficult and ethically challenging
task, since MESP2 is only expressed for a brief period
during embryogenesis, in a highly restricted domain in
the presomitic mesoderm. However, the presence or ab-
sence of such an intron does not effect our conclusions
about the effects of the 4-bp insertion onMESP2 protein
production. The insertion is located overlapping the
NCBI proposed 5′ splice site and would interrupt splic-
ing, leading to a frameshift at the same point in the
MESP2 protein.
The MESP2 gene is predicted to produce a transcript
of 1,191 bp encoding a protein of 397 amino acids with
a predicted molecular weight of 41,744 Da and isoelec-
tric point (pI) of 7.06. The human MesP2 protein has
58.1% identity with mouse MesP2, and 47.4% identity
with human MesP1. Human MesP2 amino terminus
contains a basic helix-loop-helix (bHLH) region encom-
passing 51 amino acids divided into an 11-residue basic
domain, a 13-residue helix I domain, an 11-residue loop
domain, and a 16-residue helix II domain. The loop
region is slightly longer than that found in homologues
such as paraxis. The length of the loop region is con-
served between mouse and human MesP1, MesP2, and
Thylacine 1 and 2, as well as chick mesogenin. In ad-
dition, bothMesP1 andMesP2 contain a unique CPXCP
motif immediately carboxy-terminal to the bHLH do-
main. The amino- and carboxy-terminal domains are
separated in human MesP2 by a GQ repeat region also
found in human MesP1 (2 repeats) but expanded in hu-
man MesP2 (13 repeats). Mouse MesP1 and MesP2 do
not contain GQ repeats, but they do contain two QX
repeats in the same region: mouse MesP1 QSQS; mouse
MesP2 QAQM. Hydrophobicity plots indicate that
1252 Am. J. Hum. Genet. 74:1249–1254, 2004
Figure 3 Detection of the mutation 500–503dup by direct nu-
cleotide sequencing. The sequence of a heterozygous individual (as
indicated by the arrow) (top) is comparedwith the normal homozygous
sequence (bottom).
MesP1 and MesP2 share a carboxy-terminal region that
is predicted to adopt a similar fold, although MesP2
sequences do contain a unique region at the carboxy-
terminus.
Sequence analysis of 20 ethnically matched and 10
nonmatched individuals revealed the presence of a var-
iable length polymorphism in the GQ region of human
MesP2, beginning at nucleotide 535. This region con-
tains a series of 12-bp repeat units. The smallest GQ
region detected contains two type A units (GGG CAG
GGG CAA, encoding the amino acids GQGQ), followed
by two type B units (GGA CAG GGG CAA, encoding
GQGQ) and one type C unit (GGG CAG GGG CGC,
encoding GQGR). The polymorphism comprises a var-
iation in the number of type A units, with 2, 3, or 4
being present in the sequenced individuals. The fluores-
cent PCR used to confirm the familial mutation in the
68 control chromosomes revealed 23 alleles of 2 repeats,
44 alleles of 3 repeats, and 1 allele of 4 repeats, yielding
a polymorphism information content (PIC) value of
0.3707, thus demonstrating its usefulness in linkage
analysis. The 20 nonethnically matched chromosomes
consisted of 7 alleles of 2 repeats, 12 alleles of 3 repeats,
and 1 allele of 4 repeats. Therefore, allelic frequencies
are not statistically significantly different between these
two populations ( ).Pp .41
Here we have shown that a frameshift mutation in
the human homologue of the mesoderm posterior 2 gene,
MESP2, results in AR SCD in man, and we suggest that
this association be designated “SCD, MESP2-type” (or
“SCD type 2,” to be distinguished from SCD type 1 by
mutatedDLL3). MesP2 is a member of the bHLH family
of transcriptional regulatory proteins essential to a vast
array of developmental processes (reviewed in Massari
and Murre 2000). Murine Mesp1 and Mesp2, located
on chromosome 7, are separated by ∼23 kb. They are
positioned head to head and are transcribed from the
interlocus region (Saga et al. 1996). At least two en-
hancers are involved in the expression of these genes in
mouse (Haraguchi et al. 2001), one in early mesoderm
expression and the other in presomitic mesoderm (PSM)
expression. In addition, a suppressor responsible for the
rostrally restricted expression in the PSM has been iden-
tified (Haraguchi et al. 2001). These enhancers are es-
sential to the specific and coordinated expression of the
MesP proteins. The expression of MesP1 and Mesp2 is
first detected in the mouse embryo at the onset of gas-
trulation (∼6.5 d post coitum [dpc]) and is restricted to
early nascent mesoderm (Saga et al. 1996; Kitajima et
al. 2000). At this stage, the expression domain of Mesp1
is broader than that of Mesp2, and lineage analysis of
Mesp2 expressing cells shows that they contribute to
cranial, cardiac, and extra-embryonic mesoderm (Saga
et al. 1999). Expression is then downregulated, as Mesp
transcripts are not detected later in development (Saga
et al. 1999). A second site of Mesp expression is detected
at 8.0 dpc immediately prior to somitogenesis. A pair
of MesP-expressing bands appear on each side of the
embryonic midline, at the anterior part of the PSM
where the somites are anticipated to form (Saga et al.
1997, 1999). During somitogenesis MesP1 and MesP2
continue to be expressed in single bilateral bands in the
anterior PSM. MesP2 expression within the PSM con-
tinues until about the time when somite formation ceases
(∼13.5 dpc) (Saga et al. 1997), after which Mesp ex-
pression is rapidly downregulated, as transcripts are not
detected in newly formed somites.
Alignment of MesP2 homologues from human,
mouse, Xenopus, and chick demonstrates a highly di-
vergent carboxy-terminus between species (fig. 4), and
it is unknown whether functional domains are similarly
arranged in all Mesp2 orthologues, though this is well
characterized for the Xenopus Mesp2 orthologue, Thy-
lacine (Sparrow et al. 1998). If the carboxy-terminus in
human MesP2 is required for transcriptional activation,
then the mutant form of the protein described here, lack-
ing the carboxy-terminus, would lose this function.
Mouse pups lacking MesP2 die within 20 min of birth,
presenting with short tapered trunks and abnormal seg-
mentation affecting all but a few caudal (tail) vertebrae
(Saga et al. 1997). This resembles the phenotype ofDll3-
null mice, in which the rib and vertebral architecture is
disturbed along the entire axis.
Unlike the mouse null MesP2 allele, the human mu-
tant protein retains its bHLH region and, although trun-
cated, might still dimerize, bind DNA, and thus act in
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Figure 4 Comparison of MesP2 (A) and MesP1 (B), both con-
taining a bHLH domain. MesP1 and MesP2 contain a unique CPXCP
motif immediately C-terminal to the bHLH domain.C, Predicted prod-
uct of the human MesP2 frameshift mutant. Xenopus and zebrafish
sequences (D) are shorter at the C-terminus and have the residues
C6XC in place of the CPXCP motif.
a dominant negative manner. However, the heterozygous
parents in this family demonstrate no axial skeletal de-
fects, from which we deduce that this MESP2 mutation
is recessive. Similarly, heterozygous mice are normal and
fertile (Saga et al. 1997). It is possible that a single func-
tional carboxy-terminus is sufficient to activate tran-
scription. Alternatively, MESP1 may compensate for the
absence of MESP2 function, just as MesP1 can rescue
the axial skeletal defects in MesP2-deficient mice in a
dosage-dependent manner (Saga 1998). It is also possible
that the mutant MESP2 transcript, containing a pre-
mature stop codon at 1099–1101 bp, is degraded by
nonsense-mediated RNA decay, with no truncated pro-
tein being produced (see Culbertson 1999).
In murine somitogenesis, MesP2 has a key role in es-
tablishing rostrocaudal polarity by participating in dis-
tinct Notch-signaling pathways (Takahashi et al. 2003).
Mesp2 expression is induced by Dll1-mediated (DLL1
[MIM 606582]) Notch signaling (presenilin1-indepen-
dent (PSEN1 [MIM 104311]) and Dll3-mediated Notch
signaling (presenilin1-dependent), whereas inhibition of
Mesp2 expression is achieved through presenilin1-in-
dependent Dll3-Notch signaling. Since Mesp2 can in-
hibit Dll1 expression, this complex signaling network
results in stripes of Dll1, Dll3, and Mesp2 gene expres-
sion in the anterior PSM. The extent to which this rep-
resents somitogenesis in man is unknown, except that
the phenotypes of the Mesp2 and Dll3 mutant mice
closely resemble SCD (Saga et al. 1997; Kusumi et al.
1998; Dunwoodie et al. 2002). Here we provide the first
evidence thatMESP2 is critical for normal somitogenesis
in man. Affected individuals in the family studied have
short trunks and abnormal segmentation of all verte-
brae, though the disruption to normal morphology ap-
pears most marked in the thoracic spine. The reasons
for regional variations in disruption pattern throughout
the spine are not known. Mutated MESP2 appears to
be a rare cause of SCD, since we have identified only
one affected family from a panel of 20 cases that were
DLL3 mutation–negative, including 8 cases in whom
abnormal vertebral segmentation affects the entire spine,
4 cases of spondylothoracic dysplasia, and a further 8
cases with diverse phenotypes.
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